Chardan Capital Markets Reiterates Buy Rating on Dyne Therapeutics (DYN)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| DYNEGY, Inc. (NASDAQ: DYN) | Delayed: 15.44 +0.24 (1.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.20 | 52 Week High | $22.01 | |||
| Open | $15.31 | 52 Week Low | $7.01 | |||
| Day High | $15.54 | P/E | N/A | |||
| Day Low | $15.08 | EPS | $0.00 | |||
| Volume | 4,377,363 | |||||
